These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 34334142

  • 1. Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial.
    Östbring MJ, Eriksson T, Petersson G, Hellström L.
    BMC Cardiovasc Disord; 2021 Aug 01; 21(1):367. PubMed ID: 34334142
    [Abstract] [Full Text] [Related]

  • 2. Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC): Protocol for a Randomized Controlled Trial Investigating Effects on Clinical Outcomes, Adherence, and Quality of Life.
    Östbring MJ, Eriksson T, Petersson G, Hellström L.
    JMIR Res Protoc; 2018 Feb 20; 7(2):e57. PubMed ID: 29463490
    [Abstract] [Full Text] [Related]

  • 3. Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7.
    Pedersen E, Garcia BH, Halvorsen KH, Eggen AE, Schirmer H, Waaseth M.
    BMC Cardiovasc Disord; 2021 Jan 21; 21(1):44. PubMed ID: 33478404
    [Abstract] [Full Text] [Related]

  • 4. Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design.
    Boulmpou A, Kartas A, Farmakis I, Zafeiropoulos S, Nevras V, Papadimitriou I, Tampaki A, Vlachou A, Lillis L, Koutsakis A, Karvounis H, Giannakoulas G.
    Hellenic J Cardiol; 2019 Jan 21; 60(4):249-253. PubMed ID: 30352291
    [Abstract] [Full Text] [Related]

  • 5. Effect of motivational interviewing in hypertensive patients (MIdNIgHT): study protocol for a randomized controlled trial.
    Silveira LCJ, Aliti GB, Da Silva EM, Pimentel RP, Gus M, Rabelo-Silva ER.
    Trials; 2019 Jul 09; 20(1):414. PubMed ID: 31288854
    [Abstract] [Full Text] [Related]

  • 6. Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled effectiveness study.
    Heisler M, Hofer TP, Klamerus ML, Schmittdiel J, Selby J, Hogan MM, Bosworth HB, Tremblay A, Kerr EA.
    Trials; 2010 Oct 12; 11():95. PubMed ID: 20939913
    [Abstract] [Full Text] [Related]

  • 7. Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.
    Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Lee M, Vachon A, Iliadis TL, Hollands W, Elman S, Kraft JM, Naseem S, Doheny S, Lee J, Barberio J, Patel L, Khan NF, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD.
    JAMA Intern Med; 2018 Sep 01; 178(9):1182-1189. PubMed ID: 30083727
    [Abstract] [Full Text] [Related]

  • 8. Improving Medication Adherence in Patients with Hypertension: A Randomized Trial.
    Hedegaard U, Kjeldsen LJ, Pottegård A, Henriksen JE, Lambrechtsen J, Hangaard J, Hallas J.
    Am J Med; 2015 Dec 01; 128(12):1351-61. PubMed ID: 26302142
    [Abstract] [Full Text] [Related]

  • 9. Long-term secondary prevention and outcome following acute coronary syndrome: real-world results from the Swedish Primary Care Cardiovascular Database.
    Bentzel S, Ljungman C, Hjerpe P, Schiöler L, Manhem K, Bengtsson Boström K, Kahan T, Mourtzinis G.
    Eur J Prev Cardiol; 2024 May 11; 31(7):812-821. PubMed ID: 38135289
    [Abstract] [Full Text] [Related]

  • 10. Process- and patient-reported outcomes of a multifaceted medication adherence intervention for hypertensive patients in secondary care.
    Hedegaard U, Hallas J, Ravn-Nielsen LV, Kjeldsen LJ.
    Res Social Adm Pharm; 2016 May 11; 12(2):302-18. PubMed ID: 26088274
    [Abstract] [Full Text] [Related]

  • 11. Treatment in a preventive cardiology clinic utilizing advanced practice providers effectively closes atherosclerotic cardiovascular disease risk-management gaps among a primary-prevention population compared with a propensity-matched primary-care cohort: A team-based care model and its impact on lipid and blood pressure management.
    Fentanes E, Vande Hei AG, Holuby RS, Suarez N, Slim Y, Slim JN, Slim AM, Thomas D.
    Clin Cardiol; 2018 Jun 11; 41(6):817-824. PubMed ID: 29667200
    [Abstract] [Full Text] [Related]

  • 12. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.
    Hirsch JD, Steers N, Adler DS, Kuo GM, Morello CM, Lang M, Singh RF, Wood Y, Kaplan RM, Mangione CM.
    Clin Ther; 2014 Sep 01; 36(9):1244-54. PubMed ID: 25085406
    [Abstract] [Full Text] [Related]

  • 13. The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report.
    Ferrario CM, Joyner J, Colby C, Exuzides A, Moore M, Simmons D, Bestermann W, Frech-Tamas F.
    Vasc Health Risk Manag; 2013 Sep 01; 9():391-400. PubMed ID: 23901282
    [Abstract] [Full Text] [Related]

  • 14. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
    van der Laan DM, Elders PJ, Boons CC, Bosmans JE, Nijpels G, Hugtenburg JG.
    Trials; 2017 Jan 19; 18(1):29. PubMed ID: 28103948
    [Abstract] [Full Text] [Related]

  • 15. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.
    Lee JK, Grace KA, Taylor AJ.
    JAMA; 2006 Dec 06; 296(21):2563-71. PubMed ID: 17101639
    [Abstract] [Full Text] [Related]

  • 16. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
    Weisser B, Predel HG, Gillessen A, Hacke C, Vor dem Esche J, Rippin G, Noetel A, Randerath O.
    High Blood Press Cardiovasc Prev; 2020 Apr 06; 27(2):157-164. PubMed ID: 32219670
    [Abstract] [Full Text] [Related]

  • 17. Management of vascular risk factors in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).
    Meschia JF, Voeks JH, Leimgruber PP, Mantese VA, Timaran CH, Chiu D, Demaerschalk BM, Howard VJ, Hughes SE, Longbottom M, Howard AG, Brott TG.
    J Am Heart Assoc; 2014 Nov 26; 3(6):e001180. PubMed ID: 25428209
    [Abstract] [Full Text] [Related]

  • 18. A practice-based randomized controlled trial to improve medication adherence among Latinos with hypertension: study protocol for a randomized controlled trial.
    Schoenthaler A, De La Calle F, Barrios-Barrios M, Garcia A, Pitaro M, Lum A, Rosal M.
    Trials; 2015 Jul 02; 16():290. PubMed ID: 26134837
    [Abstract] [Full Text] [Related]

  • 19. The effectiveness of daily SMS reminders in pharmaceutical care of older adults on improving patients' adherence to antihypertensive medication (SPPA): study protocol for a randomized controlled trial.
    Haramiova Z, Stasko M, Hulin M, Tesar T, Kuzelova M, Morisky DM.
    Trials; 2017 Jul 18; 18(1):334. PubMed ID: 28720121
    [Abstract] [Full Text] [Related]

  • 20. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR, Evans M, Yule C, Bohn L, Young A, Lewis M, Graboski E, Gerdy B, Ehmann W, Brady J, Lawrence L, Antunes N, Green J, Snyder S, Kirchner HL, Grams M, Perkins R.
    BMC Nephrol; 2016 Nov 08; 17(1):168. PubMed ID: 27825313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.